Defining the clinical course of multiple sclerosisFred Lublin, Chris H. Polman, Bruce F. Bebo et al.|Neurology|2014Cited by 3.1k
Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceRichard A. Rudick, Ernest Willoughby, Jack P. Antel et al.|Annals of Neurology|1997Cited by 368
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Michelle Mellion et al.|The Lancet Neurology|2019Cited by 185
Clinical outcomes assessment in multiple sclerosisRichard A. Rudick, Ernest Willoughby, Jill S. Fischer et al.|Annals of Neurology|1996Cited by 177
Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)Ellen M. Mowry, Richard A. Rudick, Robert Bermel et al.|Frontiers in Neurology|2020Cited by 91